JFLLIFE Stock Overview
Engages in the manufacture and sale of pharmaceutical products in India and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
JFL Life Sciences Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹63.00 |
52 Week High | ₹68.40 |
52 Week Low | ₹36.05 |
Beta | 0 |
11 Month Change | 5.88% |
3 Month Change | 53.66% |
1 Year Change | 28.97% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -5.26% |
Recent News & Updates
Shareholder Returns
JFLLIFE | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 10.4% | 1.9% | -0.6% |
1Y | 29.0% | 60.9% | 41.3% |
Return vs Industry: JFLLIFE underperformed the Indian Pharmaceuticals industry which returned 60.9% over the past year.
Return vs Market: JFLLIFE underperformed the Indian Market which returned 41.3% over the past year.
Price Volatility
JFLLIFE volatility | |
---|---|
JFLLIFE Average Weekly Movement | 10.4% |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 6.3% |
10% most volatile stocks in IN Market | 9.5% |
10% least volatile stocks in IN Market | 3.8% |
Stable Share Price: JFLLIFE's share price has been volatile over the past 3 months.
Volatility Over Time: JFLLIFE's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | n/a | Smiral Patel | www.jfllifesciences.com |
JFL Life Sciences Limited engages in the manufacture and sale of pharmaceutical products in India and internationally. It offers B-Lactam dry powder injections, and solid oral dosage form tablets and capsules; general solid oral dosage form tablets and capsules; and oral rehydration solutions. The company was incorporated in 2010 and is headquartered in Ahmedabad, India.
JFL Life Sciences Limited Fundamentals Summary
JFLLIFE fundamental statistics | |
---|---|
Market cap | ₹659.91m |
Earnings (TTM) | ₹33.10m |
Revenue (TTM) | ₹465.50m |
20.9x
P/E Ratio1.5x
P/S RatioIs JFLLIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
JFLLIFE income statement (TTM) | |
---|---|
Revenue | ₹465.50m |
Cost of Revenue | ₹388.50m |
Gross Profit | ₹77.00m |
Other Expenses | ₹43.90m |
Earnings | ₹33.10m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 3.01 |
Gross Margin | 16.54% |
Net Profit Margin | 7.11% |
Debt/Equity Ratio | 16.0% |
How did JFLLIFE perform over the long term?
See historical performance and comparison